Literature DB >> 10674129

Clinical and biological relevance of vein cuff anastomosis.

G Steinthorsson1, B Sumpio.   

Abstract

Since a significant number of patients do not have suitable autologous saphenous vein for femorodistal bypass, the search for alternative graft material continues. The most commonly used prosthetic material is Polytetrafluoroethylene, however because of the poor patency of these grafts in the below knee position, a variety of techniques have been tried to improve their patency. A series of studies utilizing venous cuffs at the distal anastomosis have showed improved patency of PTFE grafts. We have reviewed the biological basis for graft failure and the literature for possible mechanical explanations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10674129

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  5 in total

1.  Development of sutureless vascular connecting system for easy implantation of small-caliber artificial grafts.

Authors:  Osamu Sakai; Yasuhide Nakayama; Yasushi Nemoto; Yoshihiro Okamoto; Taiji Watanabe; Keiichi Kanda; Hitoshi Yaku
Journal:  J Artif Organs       Date:  2005       Impact factor: 1.731

2.  Development of biotube vascular grafts incorporating cuffs for easy implantation.

Authors:  Taiji Watanabe; Keiichi Kanda; Hatsue Ishibashi-Ueda; Hitoshi Yaku; Yasuhide Nakayama
Journal:  J Artif Organs       Date:  2007-03-23       Impact factor: 1.731

Review 3.  Stem cell sources for vascular tissue engineering and regeneration.

Authors:  Vivek K Bajpai; Stelios T Andreadis
Journal:  Tissue Eng Part B Rev       Date:  2012-07-03       Impact factor: 6.389

Review 4.  Electrospun silk biomaterial scaffolds for regenerative medicine.

Authors:  Xiaohui Zhang; Michaela R Reagan; David L Kaplan
Journal:  Adv Drug Deliv Rev       Date:  2009-07-28       Impact factor: 15.470

5.  Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs).

Authors:  Zhaodi Gong; Laura E Niklason
Journal:  FASEB J       Date:  2008-01-16       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.